Skip to content
Get Handle for iPhone

Ozempic side effects

Ozempic side effects, and what the label actually says

Ozempic side effects are mostly digestive: nausea, vomiting, diarrhea, stomach pain and constipation, reported most often while the dose is being stepped up. Here is what the US label reports, how semaglutide's side effects look at weight-management doses, what can help, the less talked-about effects, and the rare warning signs that need a doctor straight away.

Updated 14 min read12 sources

Handle's short daily check-in asking about nausea and the other symptoms the user chose to track
On this page
  1. The most common Ozempic side effects
  2. Semaglutide side effects at weight-management doses
  3. When Ozempic side effects start, and when they ease
  4. Common side effects, and what can help
  5. Less talked-about Ozempic side effects
  6. "Ozempic face": what it is, and what it isn't
  7. Ozempic tablets: side effects of the pill
  8. Serious Ozempic side effects
  9. Who should not take Ozempic
  10. Tracking Ozempic side effects for your prescriber
  11. Questions to ask your prescriber about Ozempic
  12. Questions people ask
  13. Sources

In short

  • The most common Ozempic side effects are nausea, vomiting, diarrhea, stomach pain and constipation. In the label's type 2 diabetes trials, nausea affected 15.8% of people on 0.5 mg and 20.3% on 1 mg, against 6.1% on placebo.1
  • The label says most reports of nausea, vomiting and diarrhea occurred during dose escalation, and in the STEP 1 trial of semaglutide at a higher dose, nausea and diarrhea were typically mild to moderate and subsided with time.1,4
  • Semaglutide is also the medicine in Wegovy, and in Wegovy's 2.4 mg weight-management trials, which used a higher dose in a different population, nausea was reported by 44%, against 16% on placebo.3
  • Serious risks are uncommon but include pancreatitis, gallbladder problems, kidney injury from dehydration and serious allergic reactions, and the label carries a boxed warning about thyroid C-cell tumors seen in rodents.1
  • European and UK regulators list NAION, an optic nerve condition that can cause sudden loss of vision, as a very rare side effect of semaglutide; the US label does not.6,7

The most common Ozempic side effects

From Ozempic's US prescribing information: two placebo-controlled trials in adults with type 2 diabetes, one with Ozempic alone and one alongside basal insulin, with 521 people on Ozempic for an average of 32.9 weeks.1

Side effectPlaceboOzempic 0.5 mgOzempic 1 mg
Nausea6.1%15.8%20.3%
Vomiting2.3%5%9.2%
Diarrhea1.9%8.5%8.8%
Stomach (abdominal) pain4.6%7.3%5.7%
Constipation1.5%5%3.1%
Indigestion (dyspepsia)1.9%3.5%2.7%
Belching (eructation)0%2.7%1.1%
Reflux (GERD)0%1.9%1.5%
Any stomach or bowel side effect15.3%32.7%36.4%

Source: Ozempic prescribing information, Table 1 and section 6.1.1 In a separate 40-week trial of the 2 mg and 1 mg doses, stomach and bowel side effects were reported by 34% and 30.8%, and no new safety signals were identified.1 Rates from different trials can't be directly compared.

Semaglutide side effects at weight-management doses

Ozempic is approved in the US for type 2 diabetes. The same medicine, semaglutide, is sold as Wegovy for weight management, and in Wegovy's 2.4 mg trials side effects were reported more often.1,3 Placebo rates are in brackets.

Side effectOzempic 0.5–1 mg (type 2 diabetes trials)Wegovy 2.4 mg (weight-management trials)
Nausea15.8–20.3% (6.1%)44% (16%)
Vomiting5–9.2% (2.3%)24% (6%)
Diarrhea8.5–8.8% (1.9%)30% (16%)
Constipation3.1–5% (1.5%)24% (11%)
Belching1.1–2.7% (0%)7% (under 1%)
FatigueReported by more than 0.4%11% (5%)
Hair lossReported after approval only3.3% (1%)
Stopped because of side effects3.1–3.8% for stomach side effects (0.4%)6.8% for any side effect (3.2%)

The two columns come from different trials in different people, so they show why semaglutide's figures vary rather than ranking the two products.1,3 More in Wegovy side effects and Ozempic vs Wegovy.

When Ozempic side effects start, and when they ease

The label describes a pattern rather than a timetable, and everyone is different.

  1. Starting out
    The dose starts low

    Ozempic's label begins with a low dose and steps it up gradually, and says why: to reduce the risk of stomach side effects. Your prescriber sets the steps.1

  2. While the dose is stepped up
    Most reports come now

    "The majority of reports of nausea, vomiting, and/or diarrhea occurred during dose escalation," the label says.1

  3. The weeks and months after
    They usually settle

    In STEP 1, a 68-week trial of semaglutide 2.4 mg, nausea and diarrhea were "typically transient and mild-to-moderate in severity and subsided with time."4

  4. If they don't settle
    Talk to your prescriber

    In the label's trials, 3.1% on 0.5 mg and 3.8% on 1 mg stopped Ozempic because of stomach side effects, against 0.4% on placebo.1 If side effects are hard to live with, tell your prescriber; decisions about your dose are theirs to make with you.

Common side effects, and what can help

General, non-drug measures. They don't replace your care team's advice, and none of them involves changing your medicine.

  • Nausea. A queasy, sick feeling. Smaller meals eaten slowly, and going easy on fried or greasy food, may help.12 Our guide to what to eat on Ozempic has Novo Nordisk's own nausea tips. Call your care team if nausea stops you eating or drinking.
  • Vomiting. Take regular sips of fluid.12 Vomiting can dehydrate you, and the label warns that dehydration can lead to kidney injury.1 Call your care team if you can't keep fluids down or it keeps happening.
  • Diarrhea. Keep drinking through the day to replace lost fluids.1 Call your care team if it's severe or doesn't settle.
  • Constipation. Ask your care team whether more fluids and fiber-containing foods, such as fruit, vegetables and whole grains, would suit you. Call them if it's severe or comes with stomach pain, because severe constipation and bowel blockage have been reported since approval.1
  • Stomach pain, indigestion and burping. Ask your care team whether smaller, plainer meals might help with mild discomfort. Stomach pain that is severe or won't go away needs urgent attention; see the warning signs below.

Check with your prescriber or pharmacist before taking any other medicine for side effects.

In Handle

A daily check-in that takes seconds

Handle asks about nausea every day and adds the symptoms you switch on, such as diarrhea, constipation or vomiting. The card stays the same length whatever you answer, so it's easy to keep up in a rough week.

Handle records what you report and never diagnoses. It is not a monitoring or emergency service: if a symptom worries you, contact your care team, and if you feel very unwell, get medical help straight away.

  • Nausea every day, plus the questions you choose
  • Add up to six tracked symptoms, such as belching, metallic taste or fatigue, or one in your own words
  • Missed a day? Add it later, up to 30 days back
  • Log each Ozempic dose and injection site alongside
Handle's short daily check-in asking about nausea and the other symptoms the user chose to track

Less talked-about Ozempic side effects

Less common, and easy to miss in the label.

  • Hair loss. Ozempic's label lists alopecia only among reports made after approval, without a trial percentage.1 At Wegovy's 2.4 mg dose, hair loss was reported by 3.3% against 1% on placebo, more often by women (4%) than men (0.9%), and that label says it was associated with weight reduction.3 No label describes it as sudden or permanent.
  • Burping and "sulfur burps". Belching (eructation) was reported by 2.7% on 0.5 mg and 1.1% on 1 mg, against none on placebo.1 "Sulfur burps" isn't a label term, and the label says nothing about smell.
  • Tiredness, dizziness and taste changes. The label lists fatigue, dizziness and a change in taste (dysgeusia) among other reactions reported by more than 0.4% of people, and headache among reports made after approval.1
  • Injection-site reactions. Discomfort or redness where you inject was reported by 0.2% in the trials.1 The label asks you to use a different injection site each week when injecting in the same body region; see Ozempic injection sites.
  • A slightly faster heart rate. Heart rate rose by an average of 2 to 3 beats per minute on Ozempic, against a fall of 0.3 on placebo.1
  • Changes in skin sensation. Dysesthesia, meaning altered skin sensation such as burning or skin pain, appears among Ozempic's reports made after approval.1

"Ozempic face": what it is, and what it isn't

"Ozempic face" isn't a label term or a diagnosis. It's an informal name for the loss of fullness in the face that can follow rapid weight loss. Cleveland Clinic describes it as a side effect of "the rapid weight loss the medication can bring" rather than of the medicine itself, and notes that it isn't limited to Ozempic.10

The American Academy of Dermatology goes further, saying GLP-1 medicines affect collagen and muscles as well as fat, which can make the face look older.11 That is one professional body's view rather than a settled finding. If changes in your face bother you, it's worth raising with your prescriber.

Ozempic tablets: side effects of the pill

Since January 2026, Ozempic is also the US name for a once-daily semaglutide tablet for type 2 diabetes, made in 1.5, 4 and 9 mg strengths.2 The label's side-effect figures come from the Rybelsus tablet trials: nausea was reported by 11–20% on the 7 and 14 mg doses, against 6% on placebo, followed by stomach pain, diarrhea, a smaller appetite, vomiting and constipation.2

The tablet is taken on an empty stomach in the morning with up to 4 ounces of water.2 It isn't in Handle's medicine list by name yet: add it under "Something else" with its name, amount and daily schedule, and doses, check-ins, weight and the report work the same. Our Ozempic tracker guide explains how to record the tablets.

Serious Ozempic side effects

These are uncommon. The label lists them as warnings, and the figures come from its trials.

  • Pancreatitis. The label warns of acute pancreatitis, including fatal cases: persistent or severe stomach pain, sometimes spreading to the back, with or without vomiting. In the diabetes trials it was confirmed in 0.3 cases per 100 patient-years on Ozempic and 0.2 on comparison treatments.1
  • Gallbladder problems. Gallstones were reported by 1.5% on 0.5 mg and 0.4% on 1 mg, against none on placebo, and gallbladder inflammation and removal have been reported since approval.1
  • Kidney injury from dehydration. Mostly in people whose nausea, vomiting or diarrhea led to dehydration; some needed dialysis.1
  • Low blood sugar with other diabetes medicines. With a sulfonylurea, 17.3% on 0.5 mg and 24.4% on 1 mg had symptomatic low blood sugar confirmed by a glucose reading, and 0.8% and 1.2% had a severe episode. On Ozempic alone it was less common: 1.6% and 3.8%, with no severe episodes.1 Your prescriber may adjust your other diabetes medicines.
  • Diabetic eye disease. In SUSTAIN 6, a two-year trial, diabetic retinopathy complications affected 3.0% on semaglutide against 1.8% on placebo, and 8.2% against 5.2% in people who already had retinopathy.1 The trial counted bleeding inside the eye, blindness, and conditions needing eye injections or laser treatment as complications.5
  • Serious allergic reactions. Anaphylaxis and angioedema have been reported. A previous serious allergic reaction to semaglutide or any of Ozempic's ingredients means it isn't for you.1
  • Severe stomach and bowel problems. Severe stomach side effects were reported by 0.4–0.8%, against none on placebo, and bowel blockage (ileus or obstruction) and severe constipation have been reported since approval. Ozempic isn't recommended with severe gastroparesis.1
  • Aspiration during anesthesia. There have been rare reports of stomach contents entering the lungs during general anesthesia or deep sedation. The label asks you to tell your healthcare providers you take Ozempic before any planned surgery or procedure.1 Guidance on what happens next differs between countries; in the UK, the regulator advises patients not to stop treatment without first discussing it with their doctor.8
  • NAION. EU and UK regulators list this optic nerve condition, which can cause sudden loss of vision, as a very rare side effect of semaglutide, affecting up to 1 in 10,000 people. It isn't in the US label.6,7
  • Thyroid C-cell tumors (boxed warning). Semaglutide caused these tumors in rodents; it's unknown whether it does in humans. Tell your care team about a lump in your neck, trouble swallowing, shortness of breath or hoarseness that won't go away.1

Who should not take Ozempic

The label is clear about who Ozempic isn't for, and about a few situations to plan for.

  • Anyone with a personal or family history of medullary thyroid carcinoma (MTC), or with multiple endocrine neoplasia syndrome type 2 (MEN 2). This is the boxed warning.1
  • Anyone who has had a serious allergic reaction to semaglutide or any of Ozempic's ingredients.1
  • People with severe gastroparesis, for whom the label says it isn't recommended.1
  • Children: its safety and effectiveness haven't been established in pediatric patients.1
  • If you're planning a pregnancy, talk to your prescriber early: the label advises stopping Ozempic at least 2 months before a planned pregnancy, because semaglutide takes a long time to leave the body.1 More in our Ozempic half-life guide.
  • Never share an Ozempic pen with anyone else.1

Tracking Ozempic side effects for your prescriber

A month from now, "I felt sick for a while after the last step up" is hard to pin down. A short daily record turns it into something your prescriber can see: which weeks, how often and how bad.

Handle keeps your Ozempic doses and injection sites, your daily check-in, weight and food on one timeline, and works the same for any semaglutide medicine; see our semaglutide tracker. It shows them side by side and doesn't claim that one explains another; making sense of it is for you and your prescriber. Our GLP-1 side effect tracker guide has more on keeping a symptom log, and our overview of GLP-1 side effects covers the whole class.

Handle PremiumPremium

Bring a clear summary to your next appointment

A consultation report gathers your Ozempic record, including any dose changes, with symptom summaries, weight history, nutrition and activity, and an optional note about what you want to discuss.

  • Share a secure link, and revoke it whenever you like
  • Your private daily notes are never included
  • Your clinician needs no account to read it

Premium is an optional subscription in the iPhone app.

Handle's consultation report for a clinician: dose record, weight history and symptom summaries

Questions to ask your prescriber about Ozempic

Good ones for the start of treatment and after any change. Weighing Ozempic against tirzepatide? Mounjaro vs Ozempic sets out the facts side by side.

  1. Which side effects should I call you about, and which can I manage at home?
  2. What should I do if I can't keep fluids down?
  3. Do my other diabetes medicines, such as insulin or a sulfonylurea, need a closer look?
  4. Given my history, how often should my eyes be checked?
  5. I have a procedure coming up. Who should I tell, and what applies to me?

Questions people ask

What are the most common side effects of Ozempic?

Nausea, vomiting, diarrhea, stomach pain and constipation. In the label's diabetes trials, nausea was reported by 15.8% on 0.5 mg and 20.3% on 1 mg, against 6.1% on placebo, and about a third of people on Ozempic had some stomach or bowel side effect.1 Most reports came while the dose was being stepped up.

When do Ozempic side effects go away?

The label doesn't give a timeline, but it says most reports of nausea, vomiting and diarrhea occurred during dose escalation.1 In the STEP 1 trial of semaglutide 2.4 mg, nausea and diarrhea were typically mild to moderate and subsided with time.4 If a side effect is severe, lasts, or stops you eating or drinking, contact your care team rather than waiting.

What are the side effects of Ozempic in the first week?

The label doesn't describe the first week on its own. Ozempic starts at a low dose that is stepped up gradually to reduce the risk of stomach side effects, and most reports of nausea, vomiting and diarrhea came during that escalation period.1 Noting how you feel each day from the start makes it easier to show your prescriber what changed.

Does Ozempic cause hair loss?

Ozempic's label lists alopecia among reports made after approval, without a figure from its trials.1 At Wegovy's 2.4 mg semaglutide dose, hair loss was reported by 3.3% against 1% on placebo, more often by women, and that label links it to weight reduction.3 No label describes it as sudden or permanent. Mention it to your care team if you notice it.

Does Ozempic make you tired?

It can. Ozempic's label lists fatigue among reactions reported by more than 0.4% of people.1 At Wegovy's higher semaglutide dose, fatigue was reported by 11% against 5% on placebo.3 If tiredness is new, severe or getting worse, tell your care team; a daily note of how you feel makes it easier to show when it started.

Does Ozempic cause constipation or diarrhea?

Both are common. In the label's trials, diarrhea affected 8.5–8.8% on Ozempic against 1.9% on placebo, and constipation 3.1–5% against 1.5%.1 The Medication Guide says drinking fluids helps reduce your chance of dehydration;1 ask your care team whether more fluids and fiber would help with constipation. Contact them if either is severe or doesn't settle, because severe constipation and bowel blockage have been reported since approval.1

Can Ozempic cause blindness?

Two different eye issues are discussed. In a two-year trial in type 2 diabetes, diabetic retinopathy complications (defined as bleeding in the eye, blindness, or conditions needing eye injections or laser treatment) affected 3.0% on semaglutide against 1.8% on placebo.1,5 Separately, EU and UK regulators list NAION as a very rare side effect.6,7 Sudden vision loss needs urgent medical help.

Does Ozempic cause cancer?

Ozempic carries a boxed warning because semaglutide caused thyroid C-cell tumors in rodents; whether it does so in humans is unknown.1 It isn't for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Tell your care team about a neck lump, trouble swallowing, shortness of breath or hoarseness that won't go away.

What are the long-term side effects of Ozempic?

Ozempic has been studied for years in outcome trials. In FLOW, a kidney trial with a median follow-up of 41 months, no new serious or severe adverse reactions were identified.1 Longer-term questions include diabetic eye complications, seen more often on semaglutide in the two-year SUSTAIN 6 trial, and the thyroid finding in rodents, whose relevance to humans is unknown.1

Are Ozempic side effects different for men and women?

Ozempic's label doesn't report its side effects by sex. The Wegovy label, for the same medicine at a higher dose, does for hair loss: 4% of women and 0.9% of men reported it, against 2% and none on placebo.3 Pregnancy plans matter too: the label advises stopping Ozempic at least 2 months before a planned pregnancy.1

Sources

  1. Novo Nordisk, via DailyMed (U.S. National Library of Medicine). Ozempic (semaglutide) injection — Prescribing Information, effective June 1, 2026.
  2. Novo Nordisk, via DailyMed (U.S. National Library of Medicine). Rybelsus (semaglutide) tablets and Ozempic (semaglutide) tablets — Prescribing Information, effective January 30, 2026.
  3. Novo Nordisk, via DailyMed (U.S. National Library of Medicine). Wegovy (semaglutide) injection and Wegovy (semaglutide) tablets — Prescribing Information, effective June 18, 2026.
  4. Wilding JPH et al., New England Journal of Medicine, via PubMed. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), 2021.
  5. Marso SP et al., New England Journal of Medicine, via PubMed. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6), 2016.
  6. European Medicines Agency. PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy, June 6, 2025, revised June 13, 2025.
  7. Medicines and Healthcare products Regulatory Agency (UK), Drug Safety Update. Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), February 5, 2026.
  8. Medicines and Healthcare products Regulatory Agency (UK), Drug Safety Update. GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation, January 28, 2025.
  9. U.S. Food and Drug Administration, Drug Safety Communication. FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications, January 13, 2026.
  10. Cleveland Clinic, Health Essentials. ‘Ozempic Face’: What It Is and How To Avoid It, March 5, 2025.
  11. American Academy of Dermatology. How can GLP-1 drugs affect my skin, hair, and nails?, updated February 17, 2026.
  12. NHS. Feeling sick (nausea), last reviewed November 17, 2023.

Written by the Handle team from the sources above, last checked on September 23, 2026. How we write: our editorial policy. Spotted something out of date? Tell us at [email protected].

Handle supports recording and conversations with your care team. It does not diagnose, and it never tells you to start, change, skip or stop a dose. This page is general information, not medical advice. Always follow your prescriber and your medicine's instructions for use.

Your everyday GLP-1 companion

Less to remember.
More to bring to your next appointment.

Doses, how you feel, food, fluids and weight in one calm record. No streaks, no scores, never dose advice.

Get Handle for iPhoneFree to start · Optional Premium subscriptionPremium is an optional subscription in the iPhone app.